Study Finds Effective Drug Combinations for High BP
Why in the news?
A study on drug optimization for high blood pressure in South Asians revealed three effective combinations, improving control rates significantly, offering guidance for hypertension management in India.
Overview of the Study:
- Conducted by the Centre for Chronic Disease Control (CCDC) in collaboration with AIIMS, India, and Imperial College, London.
- Focused on optimising drug treatment for high blood pressure in South Asians with uncontrolled hypertension.
- Tested three double anti-hypertensive drug combinations over two years.
- India, with over 300 million individuals having high blood pressure, represents a significant portion of the global hypertension burden.
Key Findings:
- Drug combinations studied:
- Amlodipine and Perindopril.
- Amlodipine and Indapamide.
- Perindopril and Indapamide.
- All three combinations proved equally effective and safe in reducing blood pressure levels.
- Approximately 70% of participants achieved blood pressure control below 140/90 mmHg.
- The success rate is five times higher than current BP control rates in India with just one pill.
- Less than 3% of participants withdrew due to adverse effects, demonstrating the drugs’ excellent safety and tolerability.
Significance and Implications:
- First randomised study focused on anti-hypertensive drug choice for South Asians.
- Offers a practical guide for clinicians to manage hypertension effectively.
- Results underscore the importance of combination therapy in improving blood pressure management outcomes.
- Promises significant impact on addressing India’s hypertension burden, which constitutes 25% of the global population.
Sources Referred:
PIB, The Hindu, Indian Express, Hindustan Times